US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Paradigm Biopharmaceuticals Limited (PAROB) 銘柄情報

Paradigm Biopharmaceuticals Limited (PAROB)

0.059

-0.001

(-1.67%)

終了 7月4日 3:00PM

Paradigm Biopharmaceuticals Limited (PAROB) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.059

( -1.67% )

買値

0.059

売値

0.075

出来高

208,946

0.059 日の範囲 0.06

0.03 52 週間の範囲 0.06

時価総額

前日終値

0.06

始値

0.06

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 2,256,608

発行済株式数

428,519,176

配当利回り

PER

-1.72

1 株当たり利益 (EPS)

-0.1

歳入

8.45k

純利益

-36.09M

Paradigm Biopharmaceuticals Limited engages in the research and development of therapeutic products for human use in Australia. Its lead candidate is Zilosul, an injectable pentosan polysulfate sodium drugs for the treatment of osteoarthritis, mucopolysaccharidosis, ross river virus, chikungunya vir... Paradigm Biopharmaceuticals Limited engages in the research and development of therapeutic products for human use in Australia. Its lead candidate is Zilosul, an injectable pentosan polysulfate sodium drugs for the treatment of osteoarthritis, mucopolysaccharidosis, ross river virus, chikungunya virus, chronic heart failure, allergic respiratory, and acute respiratory distress syndrome diseases. The company was incorporated in 2014 and is headquartered in Melbourne, Australia. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.paradigmbiopharma.com

本社

Melbourne, Australia

設立

2026

Paradigm Biopharmaceuticals Limited is listed in the sector of the オーストラリア証券取引所 with ticker PAROB. The last closing price for Paradigm Biopharmaceutic... was AUD0.06. Over the last year, Paradigm Biopharmaceutic... shares have traded in a share price range of AUD 0.03 to AUD 0.06.

Paradigm Biopharmaceutic... currently has 428,519,176 shares in issue. The market capitalisation of Paradigm Biopharmaceutic... is AUD25.28 million. Paradigm Biopharmaceutic... has a price to earnings ratio (PE ratio) of -1.72.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.007	13.4615384615	0.052	0.06	0.046	838235	0.05002937	DE
4	0.029	96.6666666667	0.03	0.06	0.03	902198	0.04915327	DE
12	0.029	96.6666666667	0.03	0.06	0.03	902198	0.04915327	DE
26	0.029	96.6666666667	0.03	0.06	0.03	902198	0.04915327	DE
52	0.029	96.6666666667	0.03	0.06	0.03	902198	0.04915327	DE
156	0.029	96.6666666667	0.03	0.06	0.03	902198	0.04915327	DE
260	0.029	96.6666666667	0.03	0.06	0.03	902198	0.04915327	DE

PAROB - Frequently Asked Questions (FAQ)

What is the current Paradigm Biopharmaceuticals Limited share price?

The current share price of Paradigm Biopharmaceuticals Limited is AUD 0.059

How many Paradigm Biopharmaceuticals Limited shares are in issue?

Paradigm Biopharmaceuticals Limited has 428,519,176 shares in issue

What is the market cap of Paradigm Biopharmaceuticals Limited?

The market capitalisation of Paradigm Biopharmaceuticals Limited is AUD 25.28M

What is the 1 year trading range for Paradigm Biopharmaceuticals Limited share price?

Paradigm Biopharmaceuticals Limited has traded in the range of AUD 0.03 to AUD 0.06 during the past year

What is the PE ratio of Paradigm Biopharmaceuticals Limited?

The price to earnings ratio of Paradigm Biopharmaceuticals Limited is -1.72

What is the cash to sales ratio of Paradigm Biopharmaceuticals Limited?

The cash to sales ratio of Paradigm Biopharmaceuticals Limited is 11.19k

What is the registered address of Paradigm Biopharmaceuticals Limited?

The registered address for Paradigm Biopharmaceuticals Limited is 500 Collins Street, Melbourne, Victoria, 3000

What is the Paradigm Biopharmaceuticals Limited website address?

The website address for Paradigm Biopharmaceuticals Limited is www.paradigmbiopharma.com

GTF

Do an AI search to learn the process that must be followed for your shares to become unrestricted. It will cost you money. You have to get an attorney's opinion and Legacy Transfer Agent also has to work on it. Both will charge you for it.. Or call your broker and discuss it with them.

RRP60

In a way the greed to earn money through any means caused the dcvax approval delay. There should not be a debate about this drug’s effectiveness. It worked on the first day it was used by dr. Liau and her british counter part. They were so impressed and took this as their life mission and did not de

privatee

privatee 5分前

Keep those posts coming,it appears a lot of eyes here. ……Excellent.

shajandr

shajandr 6分前

"$100 million New Jersey deli fraudster"

I could see $100 million for Jersey Mike's. Its Super Sub with Mike's Way toppings is a solid 9. Butt I still prefer Jimmy John's overall menu.

I tried my first Jersey Mike's sammiches in May and June in DBQ (two locations). Thum

dominik2

dominik2 7分前

Where will we open Monday yall

sam1933

sam1933 9分前

Hedera - America250 Partnership Details
https://pbs.twimg.com/media/G-t5YvBbQAAkWOn?format=jpg&name=medium

The technical architecture of the Hedera and America250 partnership relies on leveraging a public ledger to manage large-scale data validation without network congestion.

EarningsCentral

EarningsCentral 10分前

quester614

quester614 14分前

XERI was called BANJ before Duffy took it over
https://investorshub.advfn.com/uimage/uploads/2026/7/3/jodquScreenshot_2026-07-03_11.00.33_PM.png
https://www.sec.gov/Archives/edgar/data/1481504/000147793217004838/banj_8k.htm
https://investorshub.advfn.com/uimage/uploads/2026/7/3/

UPMI

My post was in response to Roger

UPMI

sam1933

sam1933 28分前

Hedera and America250 Announce Partnership to Support the Nation’s 250th Anniversary Commemoration
https://america250.org/news/hedera-and-america250-announce-partnership-to-support-the-nations-250th-anniversary-commemoration/

https://pbs.twimg.com/media/G-zzIMVakAAROpW?format=

pinkslipjunkie

pinkslipjunkie 29分前

Maybe they know dumping large amounts will get this back to .0001 no bid again in such a hurry even they know better not too...which would knock them down to selling nothing....not saying that is the case but it could be.
I still question why the convertible note holders are not aggressively

Jetmek_03052

Jetmek_03052 34分前

Unbelievable.

for those who think in years, not days.

Linda has been running DBMM for over twenty years without making a single red cent in profit. She has buried the company in debt and at the same time, saddled it with almost a BILLION outstanding shares. It can’t

ap17

Exactly!! well said.
One word of advice. Ignore the negative noise here on crypto, who are clueless on all aspects of crypto, None own anything and would like nothing more than crypto to go to zero which it won't. And ignore any daily charts

fricassee

fricassee 38分前

Apple Expands Foldable iPhone Production While Rivals Cut Output Targets: Report
by Daily Uqab July 3, 2026

https://dailyuqab.in/apple-expands-foldable-iphone-production-while-rivals-cut-output-targets-report/

newflow

newflow 44分前

Hello Ron, i don't question Gemini, i present 100% verifiable facts and ask. I don't judge Gemini.

SkyLimit2022

SkyLimit2022 48分前

LC,

Exactly. You’re really starting to bring it all together for us!
https://investorshub.advfn.com/uimage/uploads/2025/9/11/hrtkagiphy.gif
https://investorshub.advfn.com/uimage/uploads/2025/9/10/exlbjgiphy.gif

We have more than only DCVax-L to consider

newflow

newflow 48分前

SNH and PIERS said there was nothing for equity. Why would EC reveal anything to the public?. CH11 and Delaware Court of Chancery might know. There were at least $150+ Billion claims were filed and EC succeeded and took control as requested by S&G. Admins took control in fiduciary roles to the benef

rbtree

rbtree 52分前

Amounts of Gold, Platinum and Rhodium found in cap.

That's nonsense. If Bergauer wants to waste his money on "Phase 2", AS had best provide the full chain of custody assays that must be done by an independant third party, and they had best be by a reputable lab like ALS Chemex. There

rbtree

rbtree 58分前

And Phase 2 won't find anything, either. I did enjoy reading the old info, which is more than we've seen. Clearly, every one of the Shah and Schmidt assays were and are fraudulent on their face.

TightCoil

TightCoil 60分前

Loony Bin - But we love you, knuckhead

JohnnyRodz

JohnnyRodz 1時間前

Huggy Bear, Did you mean CORN artists? 🌽 The judge won't deny the Virtu/GTS Motion to Dismiss right? 6 weeks til D-Day! Get your 🍿!

JD400

JD400 1時間前

China Pulls Gold Revaluation Trigger - LFTV Ep 279

Jul 2, 2026
In this week's Live from the Vault, Andrew Maguire reveals how China is clearing the path to take control of global gold price setting, as the PBOC drains Western gold reserves and builds the infrastructure to cha

OMOLIVES

OMOLIVES 1時間前

Juvenile would be the best description.

Paradigm Biopharmaceutic...

Amundi Global Corporate ...

Metro Finance 2026 1

Transurban Finance Compa...

Thesis Gold & Silver

WisdomTree Global Ex USA...

Progress 2024 2

Amundi MDAX ESG II UCITS...

Amundi USD Corporate Bon...

Amundi S&P 500 II UCITS ...

Amundi S&P 400 US Mid Ca...

Amundi Index MSCI Pacifi...

Amundi Label ISR Actions...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。